Autres langues UCB

Actions

UCB

BE0003739530

Produits pharmaceutiques

Marché Fermé - Euronext Bruxelles 17:55:00 01/10/2026			Après clôture 21:11:07
201,30 ^EUR	-1,85%		202,65	+0,67%

30/09	Le médicament expérimental de Merck contre une maladie cutanée atteint son objectif dans une étude de phase intermédiaire	RE
30/09	UCB présente de nouvelles données sur le Bimzelx lors d'un congrès

Autres langues

30/09	Merck's experimental skin disease drug succeeds in mid-stage study
30/09	Nieuwe studiedata UCB positief voor verwachte piekomzet
30/09	UCB presenteert nieuwe studiedata tijdens EADV 2026
30/09	UCB : announces new data at EADV 2026 supporting earlier use of BIMZELX (bimekizumab) for treating hidradenitis suppurativa
29/09	UCB Presents Data From Innovative Myasthenia Gravis Portfolio At AANEM Annual Meeting And MGFA Scientific Session
29/09	UCB : data presented at 2026 AANEM Annual Meeting and MGFA Scientific Session underscore leadership in advancing targeted treatments for gMG
28/09	Why minimal symptom expression matters: raising the bar for people living with myasthenia gravis
25/09	The Best Conversations Start Early: Coffee Reflections Ahead of EADV 2026
24/09	BofA Reaffirms UCB at Buy Amid 'Very Confident' Outlook for Psoriasis Drug
13/09	Nauwelijks stijgers in Brussel
11/09	AlphaValue/Baader Europe Sees UCB Share Drop as 'Rare Window of Affordability'; Price Target Up
10/09	UCB : A rare window of affordability
09/09	UCB Receives U.S. FDA Breakthrough Therapy Designation For CIMZIA (Certolizumab Pegol) In Pregnant Women With Antiphospholipid Syndrome
09/09	UCB krijgt FDA-doorbraakstatus voor Cimzia
09/09	UCB : receives U.S. FDA Breakthrough Therapy Designation for CIMZIA (certolizumab pegol) in pregnant women with antiphospholipid syndrome (APS)
08/09	UCB : Helping families and clinicians connect the signs that may point to TK2d
06/09	Weinig uitschieters in recordhoge Bel20
03/09	Advancing the future of rare disease diagnosis: Aspire4Rare's next chapter
01/09	Global pharma companies that have publicly announced Trump drug pricing agreements
01/09	White House Cuts Deal to Lower Prescription Drug Prices With Nine Companies
01/09	Degroof Petercam verlaagt koersdoel UCB
01/09	UCB bereikt akkoord met Amerikaanse overheid
31/08	Trump announces new round of drug-pricing deals
31/08	Ucb Sa Comes to Agreement with U.S. Government to Lower the Cost of Medicine and Strengthen U.S. Manufacturing
31/08	Trump Announces Nine New Drug Pricing Deals With Pharmaceutical Companies